Molecular Insights Into Cardioembolism: NT-proBNP and D-Dimer Augment Risk Stratification and Drive

Yuhang Lin1, Lin Zhang1

  • 1Department of Neurology, The Affiliated Wenling Hospital of Wenzhou Medical University (The First People's Hospital of Wenling), Wenling, China.

Insights

This study enhances cardioembolic stroke (CE) prediction by integrating NT-proBNP and D-dimer into the STAF score. These biomarkers synergistically promote inflammation and injury via the NF-κB-NLRP3 pathway.

Area of Science:

  • Biomedical research
  • Cardiovascular science
  • Neurology

Background:

  • The STAF score aids in predicting cardioembolic stroke (CE).
  • Optimizing CE prediction requires incorporating novel biomarkers.
  • Understanding the molecular mechanisms of CE is crucial.

Purpose of the Study:

  • To enhance the STAF score for predicting CE by including NT-proBNP and D-dimer.
  • To investigate the synergistic molecular mechanisms of NT-proBNP and D-dimer in CE.

Main Methods:

  • A retrospective study of 371 acute ischemic stroke (AIS) patients.
  • Development and validation of a modified STAF score using clinical, imaging, and biochemical data.
  • In vitro and in vivo experiments using H9c2 cardiomyocytes and an AF rat model to assess molecular mechanisms.

Main Results:

  • The modified STAF score, incorporating NT-proBNP and D-dimer, showed significantly higher predictive accuracy (AUC 0.942) than the original STAF (AUC 0.846).
  • NT-proBNP and D-dimer synergistically increased cardiomyocyte apoptosis and inflammation by activating the NF-κB pathway.
  • In vivo, biomarker overexpression exacerbated cerebral injury, while knockdown mitigated it, involving the NLRP3 pathway.

Conclusions:

  • Incorporating NT-proBNP and D-dimer significantly improves the STAF score's accuracy for CE prediction.
  • NT-proBNP and D-dimer synergistically induce cardioembolic inflammation and injury through NF-κB-NLRP3 pathway activation.
  • These biomarkers represent potential therapeutic targets for CE.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
529
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
777
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
298
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
204